MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$17,047K
Free Cash flow
-$34,248K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Collaboration revenue
Other income, net
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Payable to collaboration partner
Refund liability to collaboratio...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
4,366
-
-
-
Total operating expenses
53,678
-
-
-
Loss from operations
-49,312
-
-
-
Other income, net
3,522
-
-
-
Income tax
130
-
-
-
Net loss
-22,990
-22,930
-37,267
-34,667
Depreciation and amortization
1,049
1,081
1,168
1,237
Stock-based compensation
2,610
2,908
4,843
6,402
Amortization of premiums and accretion of discounts on marketable securities
503
667
1,246
1,548
Amortization of right-of-use assets
1,000
1,003
1,091
1,095
Amortization of debt discount and debt issuance costs
81
78
78
75
Impairment of right-of-use assets and leasehold improvements
0
-
1,771
0
Prepaid expenses and other current assets
-1,280
-1,859
1,151
-2,621
Other assets
-16
-17
-4,085
-23
Accounts payable
860
-268
-3,066
2,540
Accrued liabilities and accrued clinical supply costs
-2,768
-11,023
1,089
2,514
Payable to collaboration partner
-6,512
-7,060
6,501
4,181
Deferred revenue
-3,320
-1,046
-6,237
-3,260
Refund liability to collaboration partner
3,403
12,035
11,923
12,041
Lease liabilities
-1,871
-1,763
-1,720
-1,683
Other long-term liabilities
254
33
293
0
Net cash used in operating activities
-34,217
-49,813
-41,691
-32,511
Purchase of property and equipment
31
118
0
11
Purchase of marketable securities
27,851
51,805
81,048
58,952
Maturities of marketable securities
45,002
112,871
106,646
108,505
Sale of marketable securities
0
-
0
0
Net cash provided by investing activities
17,120
60,948
25,598
49,542
Proceeds from issuance of common stock, net of issuance costs
-
-
5,282
14,701
Proceeds from the exercise of options to purchase common stock
2
25
15
-
Proceeds from debt financing, net of discount and issuance costs
-
-
0
-
Purchase of common stock under employee stock purchase plan
48
-
95
0
Net cash provided by financing activities
50
25
5,392
14,701
Net increase (decrease) in cash, cash equivalents, and restricted cash
-17,047
11,160
-10,701
31,732
Cash, cash equivalents, and restricted cash at beginning of period
78,808
67,648
78,349
34,867
Cash, cash equivalents, and restricted cash at end of period
61,761
78,808
67,648
78,349
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
ALEC Cash Flow Sankey Diagram
Sankey diagram visualizing ALEC cash flow for the period
Maturities of marketable
securities
$45,002K
(-82.03%↓ Y/Y)
Purchase of common stock
under employee stock...
$48K
(-60.66%↓ Y/Y)
Proceeds from the
exercise of options to...
$2K
Net cash provided by
investing activities
$17,120K
(-85.90%↓ Y/Y)
Net cash provided by
financing activities
$50K
(-59.02%↓ Y/Y)
Canceled cashflow
$27,882K
Net increase
(decrease) in cash, cash...
-$17,047K
(-245.08%↓ Y/Y)
Canceled cashflow
$17,170K
Stock-based compensation
$2,610K
(-83.07%↓ Y/Y)
Prepaid expenses and
other current assets
-$1,280K
(-367.78%↓ Y/Y)
Depreciation and
amortization
$1,049K
(-68.34%↓ Y/Y)
Amortization of right-of-use
assets
$1,000K
(-43.08%↓ Y/Y)
Accounts payable
$860K
(42900.00%↑ Y/Y)
Other long-term
liabilities
$254K
(20.95%↑ Y/Y)
Amortization of debt discount
and debt issuance...
$81K
(-42.14%↓ Y/Y)
Other assets
-$16K
(68.00%↑ Y/Y)
Purchase of marketable
securities
$27,851K
(-78.88%↓ Y/Y)
Purchase of property and
equipment
$31K
(3.33%↑ Y/Y)
Net cash used in
operating activities
-$34,217K
(68.85%↑ Y/Y)
Canceled cashflow
$7,150K
something is missing
$22,930K
Other income, net
$3,522K
Net loss
-$22,990K
(67.62%↑ Y/Y)
Payable to
collaboration partner
-$6,512K
(-1039.68%↓ Y/Y)
Refund liability to
collaboration partner
$3,403K
(-86.94%↓ Y/Y)
Deferred revenue
-$3,320K
(71.25%↑ Y/Y)
Canceled cashflow
$26,452K
Accrued liabilities and
accrued clinical supply...
-$2,768K
(83.23%↑ Y/Y)
Lease liabilities
-$1,871K
(41.20%↑ Y/Y)
Amortization of premiums and
accretion of discounts on...
$503K
(-86.71%↓ Y/Y)
Collaboration revenue
$4,366K
Loss from operations
-$49,312K
Canceled cashflow
$4,366K
Income tax
$130K
Total operating
expenses
$53,678K
Buy us a coffee
Alector, Inc. (ALEC)
Alector, Inc. (ALEC)